NCT06115044

Brief Summary

Overarching hypothesis In critically ill adults enteral feeding in a diurnal intermittent pattern improves patient centred outcomes. Research questions for this study Are the same derangements in metabolic and hormonal function observed in healthy volunteers when fed continuously via a nasogastric tube observed in critically ill patients and can those derangements be mitigated by intermittent diurnal feeding? Aim of this study Assess the effect of an enteral nutrition regimen mimicking the usual diurnal meal pattern on hormonal profile and metabolism in critically ill adults. This will generate novel and important proof of concept data and support progression to a clinical trial integrating investigation of physiological responses and patient centred outcomes. Objectives of this study Laboratory: Characterise patterns of hormone, lipid and metabolite response to intermittent diurnal feeding in critically ill adults. Clinical: assess feasibility, tolerability (vomiting and gastric residual volume) and efficacy (calorie delivery) of intermittent diurnal feeding in critically ill adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

December 27, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

May 25, 2025

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

October 24, 2023

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Insulin

    Plasma insulin and C-Peptide

    Peak within 3 hours of bolus feed (comparable time point in comparator)

Secondary Outcomes (12)

  • Urea

    Study day 1 and study day 2

  • Glucagon-like peptide 1

    Study day 1 and study day 2

  • Ketones

    Study day 1 and study day 2

  • Non-esterified fatty acids

    Study day 1 and study day 2

  • Triglyceride

    Study day 1 and study day 2

  • +7 more secondary outcomes

Study Arms (2)

Intermittent

EXPERIMENTAL

Bolus feeding over 30 to 60 minutes at 0800, 1300 and 1800

Procedure: Intermittent diurnal nutrition

Continuous

ACTIVE COMPARATOR

Continuous feeding over 24 hours

Procedure: Continuous

Interventions

Calculated daily nutritional requirement given as three equal bolus feeds in daytime with prolonged overnight fast

Intermittent
ContinuousPROCEDURE

Calculated daily nutritional requirement given over 24 hours

Continuous

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥18) on intensive care
  • Planned for gastric enteral nutrition (anticipated duration \>48 hours)

You may not qualify if:

  • \>24 hours after commencement of enteral nutrition
  • Gastrointestinal surgery or pathology
  • Diabetic emergencies
  • Pregnancy
  • Parenteral or jejunal nutrition
  • Trophic feed only
  • Prone positioning
  • High risk of refeeding syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southmead Hospital

Bristol, BS10 5NB, United Kingdom

Location

Related Publications (2)

  • Beattie CE, Borislava B, Smith HA, Ambler MT, White P, Milne D, Ramesh AV, Ferriman A, Fisher T, Horsley C, Jackson S, Jubainville C, Lobo K, Maxfield H, Gonzalez JT, Betts JA, Pickering AE, Thomas M. Does Intermittent Nutrition Enterally Normalise hormonal and metabolic responses to feeding in critically ill adults? The DINE-normal proof-of-concept study. Clin Nutr. 2025 Dec;55:81-89. doi: 10.1016/j.clnu.2025.10.003. Epub 2025 Oct 30.

  • Beattie CE, Thomas M, Borislavova B, Smith HA, Ambler M, White P, Hayes K, Milne D, Ramesh AV, Gonzalez JT, Betts JA, Pickering AE. Does intermittent nutrition enterally normalise hormonal and metabolic responses to feeding in critically ill adults? A protocol for the DINE-Normal proof-of-concept randomised parallel-group study. BMJ Open. 2024 Nov 24;14(11):e086540. doi: 10.1136/bmjopen-2024-086540.

MeSH Terms

Conditions

Critical IllnessIntermittent Fasting

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsFastingFeeding BehaviorBehavior

Study Officials

  • Matt Thomas

    North Bristol NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant in Intensive Care Medicine

Study Record Dates

First Submitted

October 24, 2023

First Posted

November 2, 2023

Study Start

December 27, 2023

Primary Completion

April 24, 2024

Study Completion

October 31, 2024

Last Updated

May 25, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Applications for access to the final trial dataset will be considered by the Chief Investigator and Sponsor after publication of trial results.

Locations